Credit Suisse’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $9.4M | Sell |
|
|||||
|
2023
Q4 | $10.4M | Sell |
|
|||||
|
2023
Q3 | $8.87M | Buy |
|
|||||
|
2023
Q2 | $9.63M | Buy |
|
|||||
|
2023
Q1 | $7.11M | Buy |
|
|||||
|
2022
Q4 | $7.38M | Buy |
|
|||||
|
2022
Q3 | $5.85M | Sell |
|
|||||
|
2022
Q2 | $8.45M | Buy |
|
|||||
|
2022
Q1 | $8.89M | Buy |
|
|||||
|
2021
Q4 | $8.45M | Buy |
|
|||||
|
2021
Q3 | $6.53M | Sell |
|
|||||
|
2021
Q2 | $8.85M | Buy |
|
|||||
|
2021
Q1 | $7.7M | Sell |
|
|||||
|
2020
Q4 | $13M | Buy |
|
|||||
|
2020
Q3 | $5.93M | Sell |
|
|||||
|
2020
Q2 | $7.34M | Sell |
|
|||||
|
2020
Q1 | $7.12M | Buy |
|
|||||
|
2019
Q4 | $5.7M | Buy |
|
|||||
|
2019
Q3 | $3.83M | Buy |
|
|||||
|
2019
Q2 | $2.84M | Buy |
|
|||||
|
2019
Q1 | $2.86M | Buy |
|
|||||
|
2018
Q4 | $1.71M | Sell |
|
|||||
|
2018
Q3 | $3M | Sell |
|
|||||
|
2018
Q2 | $4.1M | Sell |
|
|||||
|
2018
Q1 | $2.95M | Buy |
|
|||||
|
2017
Q4 | $2.34M | Sell |
|
|||||
|
2017
Q3 | $6.82M | Buy |
|
|||||
|
2017
Q2 | $7.85M | Sell |
|
|||||
|
2017
Q1 | $9.79M | Buy |
|
|||||
|
2016
Q4 | $8.29M | Sell |
|
|||||
|
2016
Q3 | $8.47M | Sell |
|
|||||
|
2016
Q2 | $6.91M | Buy |
|
|||||
|
2016
Q1 | $5.39M | Buy |
|
|||||
|
2015
Q4 | $6.33M | Buy |
|
|||||
|
2015
Q3 | $5.23M | Buy |
|
|||||
|
2015
Q2 | $5.34M | Buy |
|
|||||
|
2015
Q1 | $2.09M | Buy |
|
|||||
|
2014
Q4 | $889K | Buy |
|
|||||
|
2014
Q3 | $642K | Buy |
|